Red meat: why humans get MS and other primates don’t

By George Jelinek on November 7, 2015

Extraordinary! Dutch Professor of Immunobiology and long-time expert researcher in primate models of multiple sclerosis, Dr Bert t’Hart has proposed that regular consumption of red meat by humans explains why we get MS and other non-human primates (monkeys, chimpanzees, etc) don’t

WHO recommends a plant-based diet

By George Jelinek on October 27, 2015

We have been extolling the virtues of a plant-based wholefood diet for people with MS here at OMS for 16 years. And now the World Health Organisation is saying the same thing for everybody, whether they have an illness or not

Further evidence supporting the crucial role played by dietary fatty acids in autoimmunity

By Amy Williams on October 23, 2015

A paper published by authors working in the fields of neurology, food toxicology, human genetics and immunology at universities across Germany presents further evidence of the direct impact that dietary fatty acids have on central nervous system autoimmunity.

Study into extended Tysabri dosage suggests PML risk could be reduced without affecting drug’s efficacy

By Amy Williams on October 22, 2015

An ongoing study into the use of Tysabri in multiple sclerosis patients has revealed early results which suggest that the recommended dosage interval could be doubled from every 4 weeks to every 8, without any negative effect on the efficacy of the treatment

A single drop of blood in the brain can trigger autoimmunity: could this be the missing link in MS?

By George Jelinek on October 20, 2015

There are so many clues in the medical literature suggesting that a break in the tight barrier around the brain, the blood-brain-barrier (BBB), can allow the pathological process of multiple sclerosis to start

Findings of a new study could help in the treatment of chronic pain

By Amy Williams on October 19, 2015

Published in the September issue of the Journal of Neuroscience, a new study suggests further avenues are available for the research of treatment of the chronic neuropathic pain associated with multiple sclerosis, diabetes and cancer.